HER2 FISH pharmdx TM Interpretation Guide - Breast Cancer

Similar documents
HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer

IT S ABOUT TIME. IQFISH pharmdx Interpretation Guide THREEHOURSTHIRTYMINUTES. HER2 IQFISH pharmdxtm. TOP2A IQFISH pharmdxtm

Three Hours Thirty Minutes

Dako IT S ABOUT TIME. Interpretation Guide. Agilent Pathology Solutions. ALK, ROS1 and RET IQFISH probes (Dako Omnis) MET IQFISH probe (Dako Omnis)

Instant Quality FISH. The name says it all.

Instant Quality FISH. The name says it all.

Results you can trust

Breast Cancer Interpretation Guide

PRODUCT INFORMATION. New Reagents for Dako CoverStainer. Choose the H&E staining intensity you want.

HER2 IQFISH pharmdx. Code K th edition

artus EBV QS-RGQ Kit Performance Characteristics May 2012 Sample & Assay Technologies Analytical sensitivity plasma

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

Chemical compatibility of the Pall QPoint TM Docking Station - Tap Assembly with common surface disinfectants

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing

PyroMark Q24 CpG MGMT Handbook

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing

T he HER2/neu type 1 tyrosine kinase growth factor

Annexin V-FITC Apoptosis Detection Kit

MEDICAL POLICY. Proprietary Information of YourCare Health Plan

Priti Lal, MD, 1 Paulo A. Salazar, 1 Clifford A. Hudis, MD, 2 Marc Ladanyi, MD, 1 and Beiyun Chen, MD, PhD 1. Abstract

Dr. dr. Primariadewi R, SpPA(K)

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

Prediction of HER2 gene status in Her2 2 þ invasive breast cancer: a study of 108 cases comparing ASCO/CAP and FDA recommendations

MEDICAL POLICY. Proprietary Information of Excellus Health Plan, Inc. A nonprofit independent licensee of the BlueCross BlueShield Association

The following slides were presented at the TIGA Workshop, and are enclosed in the PP show format (*.pps) in order to include all presented details.

Product Introduction

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

Immunohematology. IH-QC Modular System. Select. Combine. Control.

Transform genomic data into real-life results

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY

Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY

Assessment of Breast Cancer with Borderline HER2 Status Using MIP Microarray

Prediction and Prevention of Type 1 Diabetes

Welcome! HER2 TESTING DIAGNOSTIC ACCURACY 4/11/2016

HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer

Journal of Breast Cancer

Reviewer's report. Version: 1 Date: 24 May Reviewer: Cathy Moelans. Reviewer's report:

A New Era in SFC Column Technology

Lipid Droplets Fluorescence Assay Kit

Population- based cancer survival estimates

Bio-Rad Laboratories. Hemoglobin Testing. VARIANT II Hemoglobin Testing System For HbA 1c

Know for sure! Your Power for Health. PapilloCheck and PapilloCheck high-risk HPV-Genotyping: The Clear Edge in Early Detection of Cervical Cancer.

HER2 ISH (BRISH or FISH)

BioPlex 2200 Infectious Disease Panels

Comparison of Fluorescence and Chromogenic In Situ Hybridization for Detection of HER-2/neu Oncogene in Breast Cancer

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

Infectious Disease Testing. ULTRA Product Line. Safety is not a Matter of Chance

Allied Health: Sustainable Integrated Health Care for all Australians

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors

Significance of Chromosome Changes in Hematological Disorders and Solid Tumors

Cardiac Assessment Controls

TGX and TGX Stain-Free FastCast Acrylamide Kits

Assessment Run B HER2 IHC

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Supplementary Figure 1

microrna Presented for: Presented by: Date:

HER2/neu Evaluation of Breast Cancer in 2019

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines

The next best thing to fruits and vegetables

Molecular Probes Introducing 14 new probes

CANCER. Clinical Validation of Breast Cancer Predictive Markers

Improving Food Process Control Using the

Quality in Control. ROS1 Analyte Control. Product Codes: HCL022, HCL023 and HCL024

FOOD TESTING RAPID'L.Mono Chromogenic Media. Detect Listeria Species in 24 Hours

Comparison of in situ hybridization methods for the assessment of HER-2/neu gene amplification status in breast cancer using a tissue microarray

Determination of HER2 Amplification by In Situ Hybridization. When Should Chromosome 17 Also Be Determined?

STATS Relationships between variables: Correlation


CytoPainter LysoGreen Indicator Reagent

Immunohistochemical (IHC) HER-2/neu and Fluorescent- In Situ Hybridization (FISH) Gene Amplification of Breast Cancer in Indian Women

In-Use Evaluation Report

FT-Raman Surface Mapping of Remineralized Artificial Dental Caries

Global EHS Resource Center

Assessment Run B HER2 IHC

HRM Series PCB Power Relays

Be sure! Your Power for Health. PelvoCheck CT/NG Your test kit for Chlamydia trachomatis screening and Neisseria gonorrhoeae infections

Bio-Rad Laboratories. Cardiac Assessment Controls. Value Assigned for Clinical Laboratory and Point of Care Test Systems

American Society of Cytopathology Core Curriculum in Molecular Biology

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

ab Oil Red O (Lipid Stain)

Urgent Medical Device Correction

Type 1 Diabetes Australian Research Impact Analysis

WCPT COUNTRY PROFILE December 2017 SWEDEN

PosterREPRINT INTRODUCTION. 2-D PAGE of Mouse Liver Samples. 2-D PAGE of E.coli Samples. Digestion / Cleanup. EXPERIMENTAL 1-D PAGE of BSA Samples

Tobacco control measures in the Dutch National Prevention Agreement and expected tobacco industry responses

WCPT COUNTRY PROFILE December 2017 HUNGARY

ApplicationNOTE EXACT MASS MEASUREMENT OF ACTIVE COMPONENTS OF TRADITIONAL HERBAL MEDICINES BY ORTHOGONAL ACCELERATION TIME-OF-FLIGHT.

Vysis ALK Break Apart FISH Probe Kit

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE)

European Experience and Perspective on Assessing Value for Oncology Products. Michael Drummond Centre for Health Economics, University of York

WCPT COUNTRY PROFILE December 2017 SERBIA

The health economic landscape of cancer in Europe

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Transcription:

P A T H O L O G Y HER2 FISH pharmdx TM Interpretation Guide - Breast Cancer For In Vitro Diagnostic Use FDA approved as an aid in the assessment of patients for whom Herceptin TM (trastuzumab) treatment is being considered.

HER2 FISH pharmdx Kit HER2 FISH pharmdx Kit is a direct fluorescence in situ hybridization (FISH) assay designed to quantitatively determine HER2 gene amplification in formalin-fixed, paraffin-embedded (FFPE) breast cancer tissue specimens. It is FDA approved as an aid in the assessment of patients for whom Herceptin (trastuzumab) treatment is being considered. Results from HER2 FISH pharmdx Kit are intended for use as an adjunct to the clinicopathologic information currently used for estimating prognosis in stage II, node-positive breast cancer patients. Scan path for signal counting Scoring Guide Assessable tissue Score only the invasive component of a carcinoma Avoid necrotic areas and cells with ambiguous borders Disregard nuclei with weak signal intensity and non-specifi c or high background staining Signal location Locate tumor on H&E-stained slide. Evaluate the same area on the FISH-stained slide Scan several areas of tumor cells to account for possible heterogeneity Select distinct tumor areas for assessment Begin analysis in upper left quadrant of selected area. Scan from left to right, counting signals in each tumor nucleus Adjust microscope focus to locate all signals in the individual nuclei

Breast carcinoma stained with HER2 FISH pharmdx 2 Kit Non-amplified result Red/green ratio < 2 Breast carcinoma stained with HER2 FISH pharmdx Kit Amplified result Red/green ratio 2 Signal enumeration Count HER2 (red) and CEN-17 (green) signals in nuclei in representative tumor areas Calculate the HER2/CEN-17 ratio by dividing the total number of HER2 signals by the total number of CEN-17 signals Two signals of the same size, separated by a distance equal to or less than the diameter of one signal, are counted as one signal Nuclei with high levels of HER2 gene amplification (red) may exhibit formation of signal clusters. Estimate the HER2 signal number. HER2 clusters may obscure CEN-17 (green) signals. You can check this using a specific FITC filter. Nuclei exhibiting signals of only one color should not be scored Do not score nuclei demonstrating overdigestion Ratio of HER2/CEN-17 signals HER2 Gene Status Result < 2 Non-Amplified Negative 2 Amplified Positive Results at or near the cut-off (1.8 2.2) should be interpreted with caution. In those cases, count an additional 20 nuclei and recalculate the ratio. Filter Recommendation Filters are individually designed for specific fluorochromes and for each microscope. For the interpretation of HER2 FISH pharmdx staining, the following combination of filters is recommended: A specific DAPI filter A high-quality Texas Red/FITC double filter (or specific Texas Red and FITC single filters) Fluorochrome Excitation Wavelength Emission Wavelength FITC 495 nm 520 nm Texas Red 596 nm 615 nm

Counting Guide One green signal (split) indicates the presence of one copy of chromosome 17*. One red signal indicates the presence of one copy of the HER2 gene. The ratio of HER2 to CEN-17 is 1/1 = 1; non-amplified. Three green signals (one out of focus) indicate the presence of three copies of chromosome 17. Three red signals indicate the presence of three copies of the HER2 gene. The ratio of HER2 to CEN-17 is 3/3 = 1; non-amplified. Two green signals indicate the presence of two copies of chromosome 17. Three red signals (two split signals) indicate the presence of three copies of the HER2 gene*. The ratio of HER2 to CEN-17 is 3/2 = 1.5; non-amplified. One green signal indicates the presence of one copy of chromosome 17. Five red signals indicate the presence of fi ve copies of the HER2 gene. The ratio of HER2 to CEN-17 is 5/1 = 5; amplified. Three green signals indicate the presence of three copies of chromosome 17. Approximately 12 red signals indicate the presence of 12 copies of the HER2 gene (cluster estimation). The ratio of HER2 to CEN-17 is 12/3 = 4; amplified. Do not score (nuclei are overlapping, not all areas of nuclei are visible). Do not score nuclei with signals of only one color (two green signals). Do not score (overdigested nuclei). Cluster of red signals hiding green signals. Check the green signals with a specific FITC filter, or do not score. * Two signals of the same size, separated by a distance equal to or less than the diameter of one signal, are counted as one signal.

2010 Dako PLEASE PHOTOCOPY FOR YOUR USE Scoring Sheet HER2 FISH pharmdx Kit HER2 FISH pharmdx Kit K5331 Lot: Staining Run Log ID: Count signals in 20 tumor nuclei Nucleus HER2 Score (Red) CEN-17 Score (Green) Nucleus 1 11 2 12 3 13 4 14 5 15 6 16 7 17 8 18 9 19 10 20 Total (1-10) Total (11-20) HER2 Score (Red) CEN-17 Score (Green) For determination of the HER2/CEN-17 ratio, count the number of HER2 signals and the number of CEN-17 signals in the same 20 nuclei and divide the total number of HER2 signals by the total number of CEN-17 signals. If the HER2/CEN-17 ratio is borderline (1.8 2.2), count an additional 20 nuclei and recalculate the ratio. Results at or near the cut-off (1.8 2.2) should be interpreted with caution. HER2 FISH HER2 CEN-17 HER2/CEN-17 ratio TOTAL SCORE (1-20) Ratio < 2: HER2 gene amplifi cation was not observed Ratio 2: HER2 gene amplifi cation was observed Date (Day 1) of Run: Specimen ID: Technician signature, Date Pathologist signature, Date

HER2 FISH pharmdx Complete Kit Includes Pre-Treatment Solution (20x concentrated) Pepsin, Ready-to-Use HER2/CEN-17 Probe Mix Stringent Wash Buffer (20x concentrated) Fluorescence Mounting Medium, containing DAPI Wash Buffer (20x concentrated) Coverslip Sealant The HER2 FISH pharmdx Kit contains materials necessary to perform 20 consistent, reproducible assays (22 x 22 mm target area) within a maximum of 10 individual staining runs. Product Name Size Code HER2 FISH pharmdx Kit 20 tests K5331 HercepTest (for manual use) 35 tests K5204 HercepTest for the Dako Autostainer/Autostainer Plus 50 tests K5207 HercepTest for Automated Link Platforms 50 tests SK001 Hybridizer 110V S2450 Hybridizer 220V S2451 Corporate Headquarters Denmark +45 44 85 95 00 www.dako.com Distributors in more than 60 countries Australia +61 2 9502 8700 Austria +43 1 408 43 34 0 Belgium +32 (0) 16 38 72 20 Brazil +55 11 50708300 Canada +1 905 858 8510 China +86 21 6327 1122 Denmark +45 44 85 97 56 Finland +358 9 348 73 950 France +33 1 30 50 00 50 Germany +49 40 69 69 470 Ireland +353 1 479 0568 Italy +39 02 58 078 1 Japan +81 3 5802 7211 The Netherlands +31 20 42 11 100 Norway +47 23 14 05 40 Poland +48 58 661 1879 Spain +34 93 499 05 06 Sweden +46 8 556 20 600 Switzerland +41 41 760 11 66 United Kingdom +44 (0)1 353 66 99 11 United States of America +1 805 566 6655 00198 21APR10